SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celesticas upcoming quarterly earnings report is driving attention as shares sold off sharply ahead of the results, despite traders expectations for strong AI-infrastructure demand and guidance. The move has sparked speculation about an earnings leak or stop-loss selling, while others see the pullback as pre-earnings volatility and are watching for confirmation from the report.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians steep slide to fresh 52-week lows ahead of its Q3 earnings report is dominating discussion, with traders focused on whether the R2 ramp can improve margins and ease cash-burn concerns despite strong delivery growth. Sentiment is split between investors hoping for an earnings-driven rebound and those expecting weak results or guidance to extend the decline.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Ubers reported exit from preliminary Instacart acquisition talks is the main catalyst, as DoorDash is seen as a potential buyer. Traders are split between viewing the move as avoiding a costly, potentially dilutive deal and seeing it as a missed grocery-delivery opportunity, while many criticize Ubers weak share performance.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is drawing attention around its quarterly results, with traders debating whether concerns about branded-checkout growth and margins will outweigh cash flow, buybacks and other growth initiatives. Takeover and bank-charter speculation adds bullish chatter, but remains unconfirmed; some traders are cautious about the earnings reaction.

XP, Inc. engages in the operation of technology-driven financial services platform. The firm provides customers with two principal types of offerings, financial advisory services for retail clients in Brazil, high-net-worth clients, international clients and corporate and institutional clients, and an open financial product platform providing access to over 800 investment products including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds (REITs) and others from XP, its partners and competitors. he company was founded by Guilherme Dias Fernandes Benchimol in 2001 and is headquartered in Vila Olimpia, Brazil.

XP Inc - Ordinary Shares - Class A

XP is plunging alongside Brazilian stocks after Lulas election win, as traders worry about government spending and fiscal discipline. The community is split between viewing the selloff as a politically driven overreaction and buying the dip, and warning that the volatility and uncertainty could bring further losses.

Maplebear, Inc. engages in the design and development of an online application that offers grocery delivery and pick-up services. The firm offers Instacart which enables users to connect with personal shoppers in the area who pick up and deliver groceries from local stores. The company was founded by Apoorva Mehta, Brandon Leonardo, and Max Mullen in 2012 and is headquartered in San Francisco, CA.

Maplebear Inc.

Instacart

Reports that DoorDash is in advanced talks to acquire Instacart are driving attention, with traders speculating about a takeover premium while acknowledging the talks could still collapse and a deal could face regulatory scrutiny. Some traders are holding for a possible transaction, while others question whether it will be completed.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

SpaceXs FCC filing asking that NextNavs proposed 900 MHz flexible-use license be included in satellite-to-phone rulemaking is driving attention, with bullish traders viewing it as support for the spectrums strategic value. The filing is not FCC approval or a partnership or acquisition announcement, and traders remain divided over the pending regulatory process and speculation about a potential SpaceX deal.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

AMKR is drawing attention after its Q3 revenue and EPS came in below expectations and its Q4 outlook also trailed forecasts. Traders are divided between those viewing the results and guidance as bearish and those arguing the stock is beaten down enough for a rebound, with some attributing price swings to short covering.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

Reports that DoorDash is in advanced talks to acquire Instacart are driving attention, with traders weighing the potential grocery-delivery expansion against deal-price, dilution and antitrust risks; some question why DASH is falling while Instacart rises. The talks remain uncertain, and no terms have been disclosed.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Elon Musks warning that neocloud providers face tighter financing and industry consolidation has fueled concern about Nebiuss debt-heavy data-center expansion and a sharp selloff. Bears question whether the company can fund its growth, while bulls point to its secured financing and customer commitments and note that its CEO says it has enough funding for planned capacity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation

RNA therapeutics are gaining momentum as Alnylam, Ionis, Wave Life Sciences and Arcturus advance innovative treatments targeting a range of diseases.

This Autoliv Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Analysts downgraded Accelerant, Autoliv, Compass Therapeutics, Wave Life Sciences and PG&E; price targets for CMPX and PCG were cut.read more...

Wave Life Sciences Names Monika Vnuk Chief Business Officer

(RTTNews) - On Tuesday, Wave Life Sciences Ltd. (WVE), a clinical-stage biotechnology company based in RNA medicines, announced the appointment of Monika Vnuk as the Chief Business Officer, and will join Waves executive team and lead business development, corporate development, a...

Wave Life Sciences (WVE) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates

Wave Life Sciences (WVE) delivered earnings and revenue surprises of -9.68% and -73.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?

Wave Life Sciences (WVE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?

Sarepta falls nearly 10% in a week after Dyne Therapeutics wins FDA priority review for a rival DMD therapy that could challenge Exondys 51 if approved.

New Strong Buy Stocks for July 22nd

HTLD, YEXT, ANIX, WVE and LCNB have been added to the Zacks Rank #1 (Strong Buy) List on July 22, 2026.

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.

Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.

Wave Life Sciences Inc.

WVE Stock Edges Up After Positive Early Data For Rare Disease Drug  

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>In the ongoing early-stage trial, the treatment helped the body make normal levels of a protective protein while significantly lowering levels of a harmful misfolded protein.</li><li>The company said it plans to discuss the data with the U.S. Food and Drug Administration in the middle of this year as it considers an accelerated approval pathway.</li><li>Additional trial results are expected later in 2026.</li></ul>&nbsp;Shares of Wave Life Sciences (WVE) jumped 7% after hours on Monday after the company reported encouraging early-stage clinical results for its experimental treatment for alpha-1 antitrypsin deficiency, a rare genetic disorder that can cause serious lung and liver damage.The Cambridge-based biotech said its drug WVE-006 produced promising effects in patients with the most severe form of the disease. In the ongoing early-stage trial, the treatment helped the body make normal levels of a protective protein while significantly lowering levels of a harmful misfolded protein. These improvements were seen with both every two weeks and once-monthly injections.The benefits lasted for at least three months after the last dose, the company said. The drug also allowed the body to naturally increase protein production during times of illness or stress — something current treatments cannot do. WVE-006 was generally well tolerated, with only mild to moderate side effects reported and no serious safety concerns or liver problems.Currently, the only approved treatment for the condition is weekly intravenous plasma-derived augmentation therapy, which aims to slow the progression of AATD-related lung disease by neutralizing lung-damaging enzymes. There are no approved therapies for AATD liver disease.<h2 class="st-heading-2">What’s Ahead For WVE-006?</h2>“We have now seen consistent results across multiple groups that support WVE-006’s potential to protect both the lungs and liver,” said Christopher Wright, Wave’s chief medical officer.The company said it plans to discuss the data with the U.S. Food and Drug Administration in the middle of this year as it considers an accelerated approval pathway. Additional trial results are expected later in 2026.<h2 class="st-heading-2"> How Did WVE Retail Traders React?</h2>On Stocktwits, retail sentiment around WVE stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user applauded the “great data” and voiced optimism for multiple price target revisions on Tuesday. They also voiced hopes for accelerated approval for the drug.<stembedurl>https://www.stocktwits.com/deltabeta/message/653744313</stembedurl><stembedurl>https://www.stocktwits.com/deltabeta/message/653744185</stembedurl><a href="https://stocktwits.com/symbol/WVE">WVE stock</a> has fallen 60% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/delta-ceo-fires-back-at-musk-amazon-beat-starlink-on-price-tech/cZXrH4DRems">Delta CEO Fires Back At Musk: Amazon Beat Starlink On Price And Tech</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Wave Life Sciences company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

The Cambridge-based biotech said its drug WVE-006 produced promising effects in patients with the most severe form of alpha-1 antitrypsin deficiency.

iShares Russell 2000 ETF

Vanguard Extended Market ETF

Wave Life Sciences Ltd

$HOOD (Tuesday afternoon)

$MSFT (Wednesday afternoon)

$GOOGL (Wednesday afternoon)

$AMZN (Thursday afternoon)

Which earnings release are you most excited for this week?

Drop a comment for other tickers.

Current Price	$3.21
Prev Close	$3.18
Open	$3.17
Dividend Yield	0.00%
50-Day Moving Average	$4.24
Beta	1.59
Avg. Volume	3.38M
PE Ratio	-2.93

52-Week High	$21.73
52-Week Low	$3.04
Market Capitalization	$627.19M
EPS (Annual)	-$1.21
Price to Book	1.36
Revenue Per Employee	$134,785.49

Feed

News

Sentiment

Earnings

Fundamentals

Info

WVE Fundamentals